Overview
Shuji Koide practices practicing medicine in Toyokawa, Japan.
His clinical expertise encompasses Congenital Cardiovascular Shunt, Pancreatic Cancer, and Lung Metastases.
He is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Shuji Koide
Is Shuji Koide a top-rated expert for Congenital Cardiovascular Shunt?
MediFind is an objective health platform that identifies experts based on real-world data. Shuji Koide is classified as an Experienced expert for Congenital Cardiovascular Shunt, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Shuji Koide participate in research or clinical trials?
Yes. Shuji Koide has published 8 articles and abstracts on conditions like Congenital Cardiovascular Shunt. You can view a list of Shuji Koide's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Congenital Cardiovascular ShuntMr. Koide isExperienced. Learn about Congenital Cardiovascular Shunt.
- Lung MetastasesMr. Koide isExperienced. Learn about Lung Metastases.
- Pancreatic CancerMr. Koide isExperienced. Learn about Pancreatic Cancer.